Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Rituximab × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 77 Lymphoma 48 Lymphoma, Non-Hodgkin 47 Lymphoma, Mantle-Cell 47 Lymphoma, Follicular 47 Lymphoma, B-Cell, Marginal Zone 41 Leukemia, Lymphocytic, Chronic, B-Cell 40 Lymphoma, B-Cell 28 Burkitt Lymphoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Waldenstrom Macroglobulinemia 17 Recurrence 17 Neoplasms 12 Leukemia 12 Leukemia, Hairy Cell 8 Hodgkin Disease 8 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm, Residual 4 Lymphoproliferative Disorders 4 Hematologic Diseases 4 Dendritic Cell Sarcoma, Interdigitating 4 Lymphoma, AIDS-Related 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Biphenotypic, Acute 3 Blast Crisis 3

Interventions

Magnetic Resonance Spectroscopy 6 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Biopsy 5 ulixertinib 2 trametinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 dabrafenib 2 tazemetostat 1 palbociclib 1 olaparib 1 etoposide phosphate 1 cobimetinib 1 Vemurafenib 1 Sirolimus 1 Pharmacogenomic Variants 1 Lenalidomide 1 LY3023414 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡